ORIC Pharmaceuticals, Inc. (ORIC)
NASDAQ: ORIC · Real-Time Price · USD
13.02
+0.09 (0.70%)
Aug 7, 2026, 2:41 PM EDT - Market open
ORIC Pharmaceuticals Market Cap
ORIC Pharmaceuticals has a market cap or net worth of $1.35 billion as of August 7, 2026. Its market cap has increased by 40.65% in one year.
Market Cap
1.35B
Enterprise Value
1.09B
1-Year Change
40.65%
Ranking
Category
Stock Price
$13.02
ChartMarket Cap Chart
Since April 24, 2020, ORIC Pharmaceuticals's market cap has increased from $741.98M to $1.35B, an increase of 81.89%. That is a compound annual growth rate of 9.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 1.35B | 69.41% |
| Dec 31, 2025 | 796.64M | 39.89% |
| Dec 31, 2024 | 569.48M | 13.47% |
| Dec 29, 2023 | 501.88M | 89.55% |
| Dec 30, 2022 | 264.77M | -54.26% |
| Dec 31, 2021 | 578.91M | -53.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ArriVent BioPharma | 1.44B |
| Absci | 1.41B |
| LB Pharmaceuticals | 1.38B |
| Monte Rosa Therapeutics | 1.33B |
| Jade Biosciences | 1.32B |
| Aktis Oncology | 1.30B |
| Immatics | 1.29B |
| Vor Biopharma | 1.28B |